Investigations and stories about the pharmaceutical market, access to medicines and public policies on health.
In addition to economic or altruistic motivation, anonymity plays a key role in egg or sperm donation, although an increasing number of countries require disclosure of donor identities.
More than half of European countries prohibit access to assisted reproduction for lesbians and almost a third do so for single women
The situation is much more difficult for trans and intersex people. In addition to the legal barriers, they face economic stumbling blocks: most public health systems cover only part of the costs or have very long wait lists or narrow access criteria.
Barriers in many European countries push thousands of people abroad to access assisted reproductive technology (ART) techniques. In some cases, they take out huge loans to pay for the treatments.
Doctors continue prescribing anti-anxiety medications such as lorazepam or diazepam for long periods despite the risk of addictions. Meanwhile, under-investment in psychological care is making things worse.
In many European countries, the availability of psychological treatment in the public healthcare system is inadequate or even non-existent. Barriers such as long waiting lists, co-payments and inadequate resources push people with anxiety or depression -those who can afford it- to the private system.
COVID-19 has paralysed mental health care, already weak in several European countries. During the first wave, 75% of psychiatry services were via telemedicine, but it doesn’t work for everybody.
For weeks, Spain and Italy were epicentres of the COVID-19 pandemic. Their health defences had an important gap.
The real cost that public administrations pay for CAR-T therapies is negotiated in secret, although the Ministry of Health does publish the maximum price it is willing to pay.
Together with sums of money they received from other laboratories, they were dished out a total of over 1.6 million. Most of them work in public hospitals.